−0.194 AUD
−12.47 M AUD
1.08 M AUD
40.50 M
About IMAGION BIOSYSTEMS LIMITED
Sector
Industry
Headquarters
South Melbourne
Website
Founded
2016
ISIN
AU000000IBX6
FIGI
BBG00H0JK007
Imagion Biosystems Ltd. engages in the research and development of non-radioactive and safe diagnostic imaging technology. It offers MagSense technology which does not use ionizing radiation, radioactive tracers, or strong magnetic fields; and PrecisionMRX nanoparticles, which is used for magnetic relaxometry and other biomedical applications where the magnet susceptibility of the nanoparticle can be instrumental. The company was founded by Edward R. Flynn on December 6, 2016 and is headquartered in Melbourne, Australia.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IBX is 0.035 AUD — it has increased by 2.94% in the past 24 hours. Watch IMAGION BIOSYSTEMS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange IMAGION BIOSYSTEMS LIMITED stocks are traded under the ticker IBX.
IBX stock has fallen by −22.22% compared to the previous week, the month change is a −32.69% fall, over the last year IMAGION BIOSYSTEMS LIMITED has showed a −92.05% decrease.
IBX stock is 2.86% volatile and has beta coefficient of −1.37. Track IMAGION BIOSYSTEMS LIMITED stock price on the chart and check out the list of the most volatile stocks — is IMAGION BIOSYSTEMS LIMITED there?
Today IMAGION BIOSYSTEMS LIMITED has the market capitalization of 1.51 M, it has decreased by −29.17% over the last week.
Yes, you can track IMAGION BIOSYSTEMS LIMITED financials in yearly and quarterly reports right on TradingView.
IBX net income for the last half-year is −1.53 M AUD, while the previous report showed −4.79 M AUD of net income which accounts for 68.13% change. Track more IMAGION BIOSYSTEMS LIMITED financial stats to get the full picture.
No, IBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IMAGION BIOSYSTEMS LIMITED EBITDA is −8.43 M AUD, and current EBITDA margin is −1.33 K%. See more stats in IMAGION BIOSYSTEMS LIMITED financial statements.
Like other stocks, IBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IMAGION BIOSYSTEMS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IMAGION BIOSYSTEMS LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IMAGION BIOSYSTEMS LIMITED stock shows the sell signal. See more of IMAGION BIOSYSTEMS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.